Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Bevacizumab-Based Chemotherapy Triggers Immunological Effects in Responding Multi-Treated Recurrent Ovarian Cancer Patients by Favoring the Recruitment of Effector T Cell Subsets.

Napoletano C, Ruscito I, Bellati F, Zizzari IG, Rahimi H, Gasparri ML, Antonilli M, Panici PB, Rughetti A, Nuti M.

J Clin Med. 2019 Mar 18;8(3). pii: E380. doi: 10.3390/jcm8030380.

2.

Low endometrial beta-catenin and cadherins expression patterns are predictive for primary infertility and recurrent pregnancy loss.

Bellati F, Costanzi F, De Marco MP, Cippitelli C, Stoppacciaro A, De Angelis C, Ruscito I, Rago R, Caserta D.

Gynecol Endocrinol. 2019 Aug;35(8):727-731. doi: 10.1080/09513590.2019.1579790. Epub 2019 Feb 26.

PMID:
30806528
3.

The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer: A meta-analysis.

Ruscito I, Darb-Esfahani S, Kulbe H, Bellati F, Zizzari IG, Rahimi Koshkaki H, Napoletano C, Caserta D, Rughetti A, Kessler M, Sehouli J, Nuti M, Braicu EI.

Gynecol Oncol. 2018 Jul;150(1):151-157. doi: 10.1016/j.ygyno.2018.05.006. Epub 2018 May 10.

PMID:
29753392
4.

Tumor-Derived Microvesicles Modulate Antigen Cross-Processing via Reactive Oxygen Species-Mediated Alkalinization of Phagosomal Compartment in Dendritic Cells.

Battisti F, Napoletano C, Rahimi Koshkaki H, Belleudi F, Zizzari IG, Ruscito I, Palchetti S, Bellati F, Benedetti Panici P, Torrisi MR, Caracciolo G, Altieri F, Nuti M, Rughetti A.

Front Immunol. 2017 Sep 25;8:1179. doi: 10.3389/fimmu.2017.01179. eCollection 2017.

5.

Endocrine Disrupting Chemicals and Endometrial Cancer: An Overview of Recent Laboratory Evidence and Epidemiological Studies.

Mallozzi M, Leone C, Manurita F, Bellati F, Caserta D.

Int J Environ Res Public Health. 2017 Mar 22;14(3). pii: E334. doi: 10.3390/ijerph14030334. Review.

6.

Hyperandrogenism in a postmenopausal woman: a rare case of ectopic adrenal cortical gland.

Guarino A, Di Benedetto L, Giovanale V, Rampioni Vinciguerra GL, Stoppacciaro A, Bellati F, Caserta D.

Gynecol Endocrinol. 2017 Mar;33(3):185-187. doi: 10.1080/09513590.2016.1252326. Epub 2017 Jan 19.

PMID:
28102088
7.

Tertiary cytoreduction for recurrent endometrial cancer.

Bellati F, Papadia A, Gasparri ML, Scanagatta P, Carriero F, Beneditti Panici P, Raspagliesi F.

Eur J Gynaecol Oncol. 2017;38(1):132-134.

PMID:
29767882
8.

Immunological and Clinical Impact of Cancer Stem Cells in Vulvar Cancer: Role of CD133/CD24/ABCG2-Expressing Cells.

Napoletano C, Bellati F, Ruscito I, Pernice M, Zizzari IG, Caponnetto S, Tomao F, Frigerio L, Liberati M, Rughetti A, Caserta D, Panici PB, Nuti M.

Anticancer Res. 2016 Oct;36(10):5109-5116.

PMID:
27798870
9.

Sentinel Node Mapping in Cervical and Endometrial Cancer: Indocyanine Green Versus Other Conventional Dyes-A Meta-Analysis.

Ruscito I, Gasparri ML, Braicu EI, Bellati F, Raio L, Sehouli J, Mueller MD, Panici PB, Papadia A.

Ann Surg Oncol. 2016 Oct;23(11):3749-3756. doi: 10.1245/s10434-016-5236-x. Epub 2016 May 9. Review.

PMID:
27160526
10.

Laparoscopic versus laparotomic surgery for adnexal masses: role in elderly.

Pulcinelli FM, Schimberni M, Marci R, Bellati F, Caserta D.

World J Surg Oncol. 2016 Apr 7;14:105. doi: 10.1186/s12957-016-0861-1.

11.

Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial.

Antonilli M, Rahimi H, Visconti V, Napoletano C, Ruscito I, Zizzari IG, Caponnetto S, Barchiesi G, Iadarola R, Pierelli L, Rughetti A, Bellati F, Panici PB, Nuti M.

Int J Oncol. 2016 Apr;48(4):1369-78. doi: 10.3892/ijo.2016.3386. Epub 2016 Feb 8.

12.

Circulating tumor cells as trigger to hematogenous spreads and potential biomarkers to predict the prognosis in ovarian cancer.

Gasparri ML, Savone D, Besharat RA, Farooqi AA, Bellati F, Ruscito I, Panici PB, Papadia A.

Tumour Biol. 2016 Jan;37(1):71-5. doi: 10.1007/s13277-015-4299-9. Epub 2015 Oct 26. Review.

PMID:
26500096
13.

When Does Neoadjuvant Chemotherapy Really Avoid Radiotherapy? Clinical Predictors of Adjuvant Radiotherapy in Cervical Cancer.

Papadia A, Bellati F, Bogani G, Ditto A, Martinelli F, Lorusso D, Donfrancesco C, Gasparri ML, Raspagliesi F.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S944-51. doi: 10.1245/s10434-015-4799-2. Epub 2015 Aug 13.

PMID:
26268452
14.

Thrombotic thrombocytopenic purpura during pregnancy versus imitator of preeclampsia.

Gasparri ML, Bellati F, Brunelli R, Perrone G, Pecorini F, Papadia A, Meloni G, Trisolini SM, Gozzer M, Domenici L, Lecce F, Benedetti Panici P.

Transfusion. 2015 Oct;55(10):2516-8. doi: 10.1111/trf.13207. Epub 2015 Aug 10.

PMID:
26260740
15.

Pleural metastasis of ovarian cancer. A price to pay for debulking the upper abdomen.

Perniola G, Riganelli L, Palaia I, Bellati F, Benedetti-Panici P.

Minerva Ginecol. 2015 Aug;67(4):384-5. No abstract available.

PMID:
26149814
16.

The Macrophage Galactose-Type C-Type Lectin (MGL) Modulates Regulatory T Cell Functions.

Zizzari IG, Martufi P, Battisti F, Rahimi H, Caponnetto S, Bellati F, Nuti M, Rughetti A, Napoletano C.

PLoS One. 2015 Jul 6;10(7):e0132617. doi: 10.1371/journal.pone.0132617. eCollection 2015.

17.

Surgical Treatment of Recurrent Endometrial Cancer: Time for a Paradigm Shift.

Papadia A, Bellati F, Ditto A, Bogani G, Gasparri ML, Di Donato V, Martinelli F, Lorusso D, Benedetti-Panici P, Raspagliesi F.

Ann Surg Oncol. 2015 Dec;22(13):4204-10. doi: 10.1245/s10434-015-4504-5. Epub 2015 Mar 17.

PMID:
25777095
18.

Oophorectomy and hysterectomy and cancer incidence in the Cancer Prevention Study-II Nutrition Cohort.

Papadia A, Bogani G, Bellati F, Raspagliesi F.

Obstet Gynecol. 2014 Oct;124(4):840-1. doi: 10.1097/AOG.0000000000000491. No abstract available.

PMID:
25244454
19.

BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients--a study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD).

Ruscito I, Dimitrova D, Vasconcelos I, Gellhaus K, Schwachula T, Bellati F, Zeillinger R, Benedetti-Panici P, Vergote I, Mahner S, Cacsire-Tong D, Concin N, Darb-Esfahani S, Lambrechts S, Sehouli J, Olek S, Braicu EI.

Eur J Cancer. 2014 Aug;50(12):2090-8. doi: 10.1016/j.ejca.2014.05.001. Epub 2014 Jun 2.

PMID:
24889916
20.

Surgical treatment of an isolated omental cervical cancer recurrence: report of a case and review of the literature.

Gasparri ML, Bellati F, Pernice M, Di Donato V, Morano G, Marchetti C, Donfrancesco C, Antonilli M, Benedetti Panici P.

Tumori. 2014 Mar-Apr;100(2):e52-4. doi: 10.1700/1491.16437. Review.

PMID:
24852877
21.

Microvesicle cargo of tumor-associated MUC1 to dendritic cells allows cross-presentation and specific carbohydrate processing.

Rughetti A, Rahimi H, Belleudi F, Napoletano C, Battisti F, Zizzari IG, Antonilli M, Bellati F, Wandall HH, Benedetti Panici P, Burchell JM, Torrisi MR, Nuti M.

Cancer Immunol Res. 2014 Feb;2(2):177-86. doi: 10.1158/2326-6066.CIR-13-0112-T. Epub 2013 Oct 28.

22.

Effects of unilateral ovariectomy on female fertility outcome.

Bellati F, Ruscito I, Gasparri ML, Antonilli M, Pernice M, Vallone C, Morano G, Chirletti P, Berloco PB, Panici PB.

Arch Gynecol Obstet. 2014 Aug;290(2):349-53. doi: 10.1007/s00404-014-3194-8. Epub 2014 Mar 11.

PMID:
24615568
23.

Gene expression profile of patients with Mayer-Rokitansky-Küster-Hauser syndrome: new insights into the potential role of developmental pathways.

Nodale C, Ceccarelli S, Giuliano M, Cammarota M, D'Amici S, Vescarelli E, Maffucci D, Bellati F, Panici PB, Romano F, Angeloni A, Marchese C.

PLoS One. 2014 Mar 7;9(3):e91010. doi: 10.1371/journal.pone.0091010. eCollection 2014.

24.

Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cells.

Paroli M, Bellati F, Videtta M, Focaccetti C, Mancone C, Donato T, Antonilli M, Perniola G, Accapezzato D, Napoletano C, Nuti M, Bartolazzi A, Panici PB, Tripodi M, Palombo F, Barnaba V.

Int J Cancer. 2014 Apr 15;134(8):1823-34. doi: 10.1002/ijc.28515. Epub 2013 Oct 22. Erratum in: Int J Cancer. 2014 Jul 15;135(2):E1.

25.

Chemotherapy in elderly patients with gynecological cancer.

Palaia I, Loprete E, Musella A, Marchetti C, Di Donato V, Bellati F, Benedetti Panici P.

Oncology. 2013;85(3):168-72. doi: 10.1159/000350859. Epub 2013 Aug 30.

PMID:
24008766
26.

CO2 laser treatment for Bartholin gland abscess: ultrasound evaluation of risk recurrence.

Di Donato V, Bellati F, Casorelli A, Giorgini M, Perniola G, Marchetti C, Palaia I, Benedetti Panici P.

J Minim Invasive Gynecol. 2013 May-Jun;20(3):346-52. doi: 10.1016/j.jmig.2012.12.003. Epub 2013 Feb 4.

PMID:
23380446
27.

Monoclonal antibodies therapies for ovarian cancer.

Leone Roberti Maggiore U, Bellati F, Ruscito I, Gasparri ML, Alessandri F, Venturini PL, Ferrero S.

Expert Opin Biol Ther. 2013 May;13(5):739-64. doi: 10.1517/14712598.2013.767328. Epub 2013 Feb 4. Review.

PMID:
23373587
28.

Detecting particles flowing through interdigitated 3D microelectrodes.

Bianchi E, Rollo E, Kilchenmann S, Bellati FM, Accastelli E, Guiducci C.

Conf Proc IEEE Eng Med Biol Soc. 2012;2012:5002-5. doi: 10.1109/EMBC.2012.6347116.

PMID:
23367051
29.

Interaction between Treg cells and angiogenesis: a dark double track.

Gasparri ML, Bellati F, Napoletano C, Panici PB, Nuti M.

Int J Cancer. 2013 May 15;132(10):2469. doi: 10.1002/ijc.27920. Epub 2012 Nov 20. No abstract available.

30.

First case of isolated vaginal metastasis from breast cancer treated by surgery.

Bellati F, Palaia I, Gasparri ML, Musella A, Panici PB.

BMC Cancer. 2012 Oct 17;12:479. doi: 10.1186/1471-2407-12-479.

31.

Minimal invasive approaches for large ovarian cysts: a careful choice.

Bellati F, Gasparri ML, Ruscito I, Caccetta J, Benedetti Panici P.

Arch Gynecol Obstet. 2013 Mar;287(3):615-6. doi: 10.1007/s00404-012-2560-7. Epub 2012 Sep 18. No abstract available.

PMID:
22987258
32.

Past, present and future strategies of immunotherapy in gynecological malignancies.

Bellati F, Napoletano C, Ruscito I, Visconti V, Antonilli M, Gasparri ML, Zizzari IG, Rahimi H, Palaia I, Rughetti A, Benedetti Panici P, Nuti M.

Curr Mol Med. 2013 May;13(4):648-69.

PMID:
22934850
33.

Olaparib, PARP1 inhibitor in ovarian cancer.

Marchetti C, Imperiale L, Gasparri ML, Palaia I, Pignata S, Boni T, Bellati F, Benedetti Panici P.

Expert Opin Investig Drugs. 2012 Oct;21(10):1575-84. Epub 2012 Jul 13. Review.

PMID:
22788971
34.

Intraperitoneal chemotherapy by ultrasound-guided direct puncture in recurrent ovarian cancer: feasibility, compliance, and complications.

Benedetti-Panici P, Perniola G, Marchetti C, Pernice M, Donfrancesco C, Di Donato V, Tomao F, Palaia I, Graziano M, Basile S, Bellati F.

Int J Gynecol Cancer. 2012 Jul;22(6):1069-74. doi: 10.1097/IGC.0b013e31825736b2.

PMID:
22665042
35.

Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation.

Napoletano C, Zizzari IG, Rughetti A, Rahimi H, Irimura T, Clausen H, Wandall HH, Belleudi F, Bellati F, Pierelli L, Frati L, Nuti M.

Eur J Immunol. 2012 Apr;42(4):936-45. doi: 10.1002/eji.201142086.

36.

Response criteria can be misleading when drawing conclusion regarding neoadjuvant chemotherapy in advanced ovarian cancer.

Bellati F, Gasparri ML, Caccetta J, Palaia I, Benedetti panici P.

J Surg Oncol. 2012 Sep 15;106(4):529; author reply 527-8. doi: 10.1002/jso.23087. Epub 2012 Apr 4. No abstract available. Erratum in: J Surg Oncol. 2013 May;107(6):680. Filippo, Bellati [corrected to Bellati, Filippo], Luisa, Gasparri Maria [corrected to Gasparri, Maria Luisa], Jlenia, Caccetta [corrected to Caccetta, Jlenia],Innocenza, Palaia [corrected to Palaia, Innocenza], Pierluigi, Benedetti Panici [corrected to Ben.

PMID:
22488017
37.

Simple extrafascial trachelectomy and pelvic bilateral lymphadenectomy in early stage cervical cancer.

Palaia I, Musella A, Bellati F, Marchetti C, Di Donato V, Perniola G, Benedetti Panici P.

Gynecol Oncol. 2012 Jul;126(1):78-81. doi: 10.1016/j.ygyno.2012.04.004. Epub 2012 Apr 6.

PMID:
22487540
38.

The web as a snack.

Serino FM, Bellati F.

Prev Med. 2012 Mar-Apr;54(3-4):286. doi: 10.1016/j.ypmed.2012.01.002. Epub 2012 Jan 20. No abstract available.

PMID:
22281065
39.

Monoclonal antibodies in gynecological cancer: a critical point of view.

Bellati F, Napoletano C, Gasparri ML, Visconti V, Zizzari IG, Ruscito I, Caccetta J, Rughetti A, Benedetti-Panici P, Nuti M.

Clin Dev Immunol. 2011;2011:890758. doi: 10.1155/2011/890758. Epub 2011 Dec 26. Review.

40.

Laparoscopically guided minilaparotomy: a minimally invasive approach for the treatment of gynaecologic diseases in morbidly obese patients.

Benedetti Panici P, Perniola G, Pernice M, Antonilli M, Achilli C, Di Donato V, Bellati F.

Eur J Obstet Gynecol Reprod Biol. 2012 Feb;160(2):210-4. doi: 10.1016/j.ejogrb.2011.11.010. Epub 2011 Dec 2.

PMID:
22136884
41.

Current knowledge and open issues regarding bevacizumab in gynaecological neoplasms.

Bellati F, Napoletano C, Gasparri ML, Ruscito I, Marchetti C, Pignata S, Tomao F, Benedetti Panici P, Nuti M.

Crit Rev Oncol Hematol. 2012 Jul;83(1):35-46. doi: 10.1016/j.critrevonc.2011.09.006. Epub 2011 Nov 4. Review.

PMID:
22056314
42.

Thinking twice before abandoning first-line chemotherapy in ovarian cancer: report of two cases and literature review. Passing from tri-weekly to weekly regimens.

Marchetti C, Bellati F, Musella A, Napoletano C, Perniola G, Di Donato V, Pignata S, Nuti M, Panici PB.

Int J Clin Oncol. 2012 Aug;17(4):385-9. doi: 10.1007/s10147-011-0300-9. Epub 2011 Sep 3.

PMID:
21892670
43.

HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy.

Zizzari IG, Veglia F, Taurino F, Rahimi H, Quaglino E, Belleudi F, Riccardo F, Antonilli M, Napoletano C, Bellati F, Benedetti-Panici P, Torrisi MR, Frati L, Nuti M, Rughetti A.

J Mol Med (Berl). 2011 Dec;89(12):1231-40. doi: 10.1007/s00109-011-0794-7. Epub 2011 Aug 16.

44.

Immune effects of trastuzumab.

Nuti M, Bellati F, Visconti V, Napoletano C, Domenici L, Caccetta J, Zizzari IG, Ruscito I, Rahimi H, Benedetti-Panici P, Rughetti A.

J Cancer. 2011;2:317-23. Epub 2011 May 25.

45.

Is there a real standard for stage IVa cervical cancer?

Bellati F, Gasparri ML, Benedetti Panici P.

Gynecol Oncol. 2011 Oct;123(1):174-5; author reply 175. doi: 10.1016/j.ygyno.2011.05.015. Epub 2011 Jun 16. No abstract available.

PMID:
21683431
46.

Invasive vulvar carcinoma and the question of the surgical margin.

Palaia I, Bellati F, Calcagno M, Musella A, Perniola G, Panici PB.

Int J Gynaecol Obstet. 2011 Aug;114(2):120-3. doi: 10.1016/j.ijgo.2011.02.012. Epub 2011 Jun 12.

PMID:
21669423
47.

Role of chemotherapy in the management of vulvar carcinoma.

Tomao F, Di Tucci C, Marchetti C, Perniola G, Bellati F, Panici PB.

Crit Rev Oncol Hematol. 2012 Apr;82(1):25-39. doi: 10.1016/j.critrevonc.2011.04.008. Epub 2011 May 20. Review.

PMID:
21601474
48.

Vaginal cancer.

Di Donato V, Bellati F, Fischetti M, Plotti F, Perniola G, Panici PB.

Crit Rev Oncol Hematol. 2012 Mar;81(3):286-95. doi: 10.1016/j.critrevonc.2011.04.004. Epub 2011 May 14. Review.

PMID:
21571543
49.

Vaginal reconstruction with the Abbè-McIndoe technique: from dermal grafts to autologous in vitro cultured vaginal tissue transplant.

Panici PB, Ruscito I, Gasparri ML, Maffucci D, Marchese C, Bellati F.

Semin Reprod Med. 2011 Jan;29(1):45-54. doi: 10.1055/s-0030-1268703. Epub 2011 Feb 24. Review.

PMID:
21351049
50.

Feasibility and safety of type C2 total extraperitoneal abdominal radical hysterectomy (TEARH) for locally advanced cervical cancer.

Panici PB, Di Donato V, Plotti F, Musella A, Sansone M, Angioli R, Perniola G, Bellati F.

Gynecol Oncol. 2011 Mar;120(3):423-9. doi: 10.1016/j.ygyno.2010.12.348. Epub 2011 Feb 1.

PMID:
21288562

Supplemental Content

Loading ...
Support Center